NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T1AM treatment

Obesity

Volumn 21, Issue 12, 2013, Pages 2538-2544

  Haviland, J A ^a   Reiland, H ^b   Butz, D E ^a   Tonelli, M ^a   Porter, W P ^a   Zucchi, R ^c   Scanlan, T S ^d   Chiellini, G ^b,c   Assadi Porter, F M ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Department of Biochemistry ^*  (United States)

^c UNIVERSITY OF PISA   (Italy)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; 3 IODOTHYRONAMINE; ANTIOBESITY AGENT; GLYCINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BREATHING; CAVITY RING DOWN SPECTROSCOPY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; FEMALE; FOOD INTAKE; LIPOLYSIS; LOW DRUG DOSE; METABOLOMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PROTEIN DEGRADATION; SPECTROSCOPY; TREATMENT DURATION; WEIGHT REDUCTION;

MUS;

3-HYDROXYBUTYRIC ACID; ANIMALS; BODY WEIGHT; BREATH TESTS; DIETARY PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCINE; LIPOLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; MICE; OBESITY; THYRONINES; VALINE; WEIGHT LOSS;

EID: 84889671759     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20391     Document Type: Article

References (21)

1. Scanlan TS, Suchland KL, Hart ME, et al. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 2004; 10: 638-642.
2. Regard JB, Kataoka H, Cano DA, et al. Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 2007; 117: 4034-4043.
3. Braulke LJ, Klingenspor M, DeBarber A, et al. 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. J Comp Physiol B 2008; 178: 167-177.
4. Klieverik LP, Foppen E, Ackermans MT, et al. Central effects of thyronamines on glucose metabolism in rats. J Endocrinol 2009; 201: 377-386.
5. Axelband F, Dias J, Ferrao FM, Einicker-Lamas M,. Nongenomic signaling pathways triggered by thyroid hormones and their metabolite 3-iodothyronamine on the cardiovascular system. J Cell Physiol 2011; 226: 21-28.
6. Chiellini G, Frascarelli S, Ghelardoni S, et al. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J 2007; 21: 1597-1608.
7. Ju H, So H, Ha K, et al. Sustained torpidity following multi-dose administration of 3-iodothyronamine in mice. J Cell Physiol 2010; 226: 853-858.
8. Saba A, Chiellini G, Frascarelli S, et al. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 2010; 151: 5063-5073.
9. 6-thyroxine. J Endocrinol 2010; 206: 327-334.
10. Hoefig CS, Kohrle J, Brabant G, et al. Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay. J Clin Endocrinol Metab 2011; 96: 1864-1872.
11. Scanlan TS,. Endogenous 3-iodothyronamine (T1AM): more than we bargained for. J Clin Endocrinol Metab 2011; 96: 1674-1676.
12. Dhillo WS, Bewick GA, White NE, et al. The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents. Diabetes Obes Metab 2009; 11: 251-260.
13. Zucchi R, Chiellini G, Scanlan TS, Grandy DK,. Trace amine-associated receptors and their ligands. Br J Pharmacol 2006; 149: 967-978.
14. Frascarelli S, Ghelardoni S, Chiellini G, et al. Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors. Eur J Pharmacol 2008; 587: 231-236.
15. Doyle KP, Suchland KL, Ciesielski TM, et al. Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke 2007; 38: 2569-2576.
16. 2 in breath due to lipopolysacchride-induced acute phase response. Rapid Commun Mass Spectrom 2009; 23: 3729-3735.
17. Haviland JA, Tonelli M, Haughey DT, Porter WP, Assadi-Porter FM,. Novel diagnostics of metabolic dysfunction in breath and plasma by selective isotope assisted labeling (SIAL). Metabolism 2012; 8: 1162-1170.
18. DeNiro MJ, Epstein S,. Mechanism of carbon isotope fractionation associated with lipid synthesis. Science 1977; 197: 261-263.
19. 2. Biomed Mass Spectrom 1984; 11: 557-561.
20. 2: its advantages and potential application to field research to infer diet, changes in diet over time, and substrate metabolism in birds. Integr Comp Biol 2002; 42: 21-33.
21. Manni ME, De Siena G, Saba A, et al. 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mouse. Br J Pharmacol 2012; 166: 650-658.